Business

Canadian CBD Company Closes $20 Million U.S. Pharma Acquisition

Canadian CBD Company Closes $20 Million U.S. Pharma Acquisition.

articleAlternate Health CorpJune 20, 20193/company/alternate-health-corp/news/canadian-cbd-company-closes-dollar20-million-us-pharma-acquisition
Canadian CBD Company Closes $20 Million U.S. Pharma Acquisition

About this update from Alternate Health Corp

[{"type":"text","content":"\n\n\n\nCanadian CBD Company Closes $20 Million U.S. Pharma Acquisition\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n.prnsbb1{\nBORDER-BOTTOM:1pt\n}\n.prnsbr1{\nBORDER-RIGHT:1pt\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n.prnsbt1{\nBORDER-TOP:1pt\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n.prnsbl1{\nBORDER-LEFT:1pt\n}\n\n\n\n\n\n\nCanadian CBD Company Closes $20 Million U.S. Pharma Acquisition\nCanada NewsWire\nTORONTO, June 20, 2019\n\n\n\nAlternate Health closes Blaine Labs acquisition, launches new product\n TORONTO, June 20, 2019 /CNW/ - Alternate Health Corp., (\"Alternate Health\" \"AHC\" or the \"Company\") (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that the Company has closed an amended acquisition agreement (the \"Agreement\") to acquire 100% of Blaine Labs Inc. (\"Blaine Labs\").\n\n \n \n\n \n\"I am excited to get started with Alternate Health, locking in the company's software solutions into our distribution system,\" says Dr. Robert Blaine, founder of Blaine Labs. \"We are developing new hemp-derived products for our network and we anticipate strong demand from both patients and distributors.\"\nIn addition to the closing of the Agreement, Alternate Health would like to announce the immediate launch of a new hemp-derived product: Hempnesic Pain-Relieving Gel. The new product is currently available through Blaine Labs physician network and distribution partners. Alternate Health is actively soliciting sales agents for international expansion as well. \n\"With Dr. Blaine's experience and product expertise, we believe we are deeply poised for success in the hemp-derived CBD industry,\" says Howard Mann, CEO of Alternate Health. \"We are excited to add Blaine Labs revenues to our Q2 results and we expect strong growth from the launch of new hemp-based products.\"\nAccording to a report by industry rese...

More updates from Alternate Health Corp